Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W1974847342', 'doi': 'https://doi.org/10.1016/j.lungcan.2014.05.008', 'title': 'AKT inhibition synergistically enhances growth-inhibitory effects of gefitinib and increases apoptosis in non-small cell lung cancer cell lines', 'display_name': 'AKT inhibition synergistically enhances growth-inhibitory effects of gefitinib and increases apoptosis in non-small cell lung cancer cell lines', 'publication_year': 2014, 'publication_date': '2014-06-02', 'ids': {'openalex': 'https://openalex.org/W1974847342', 'doi': 'https://doi.org/10.1016/j.lungcan.2014.05.008', 'mag': '1974847342', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/24957682'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1016/j.lungcan.2014.05.008', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S100767427', 'display_name': 'Lung Cancer', 'issn_l': '0169-5002', 'issn': ['0169-5002', '1872-8332'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320990', 'host_organization_name': 'Elsevier BV', 'host_organization_lineage': ['https://openalex.org/P4310320990'], 'host_organization_lineage_names': ['Elsevier BV'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5070839902', 'display_name': 'M. Puglisi', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1325846038', 'display_name': 'Royal Marsden NHS Foundation Trust', 'ror': 'https://ror.org/0008wzh48', 'country_code': 'GB', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1325846038']}, {'id': 'https://openalex.org/I142947616', 'display_name': 'Institute of Cancer Research', 'ror': 'https://ror.org/043jzw605', 'country_code': 'GB', 'type': 'education', 'lineage': ['https://openalex.org/I124357947', 'https://openalex.org/I142947616']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'M. Puglisi', 'raw_affiliation_strings': ['The Drug Development Unit, Divisions of Cancer Therapeutics & Clinical Studies, The Institute of Cancer Research & The Royal Marsden NHS Foundation Trust, London, UK', 'The Lung Unit, The Royal Marsden NHS Foundation Trust, London, UK'], 'affiliations': [{'raw_affiliation_string': 'The Lung Unit, The Royal Marsden NHS Foundation Trust, London, UK', 'institution_ids': ['https://openalex.org/I1325846038']}, {'raw_affiliation_string': 'The Drug Development Unit, Divisions of Cancer Therapeutics & Clinical Studies, The Institute of Cancer Research & The Royal Marsden NHS Foundation Trust, London, UK', 'institution_ids': ['https://openalex.org/I142947616', 'https://openalex.org/I1325846038']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5026745416', 'display_name': 'Parames Thavasu', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I142947616', 'display_name': 'Institute of Cancer Research', 'ror': 'https://ror.org/043jzw605', 'country_code': 'GB', 'type': 'education', 'lineage': ['https://openalex.org/I124357947', 'https://openalex.org/I142947616']}, {'id': 'https://openalex.org/I1325846038', 'display_name': 'Royal Marsden NHS Foundation Trust', 'ror': 'https://ror.org/0008wzh48', 'country_code': 'GB', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1325846038']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'P. Thavasu', 'raw_affiliation_strings': ['The Drug Development Unit, Divisions of Cancer Therapeutics & Clinical Studies, The Institute of Cancer Research & The Royal Marsden NHS Foundation Trust, London, UK'], 'affiliations': [{'raw_affiliation_string': 'The Drug Development Unit, Divisions of Cancer Therapeutics & Clinical Studies, The Institute of Cancer Research & The Royal Marsden NHS Foundation Trust, London, UK', 'institution_ids': ['https://openalex.org/I142947616', 'https://openalex.org/I1325846038']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5017518419', 'display_name': 'Adam Stewart', 'orcid': 'https://orcid.org/0000-0002-7688-0281'}, 'institutions': [{'id': 'https://openalex.org/I142947616', 'display_name': 'Institute of Cancer Research', 'ror': 'https://ror.org/043jzw605', 'country_code': 'GB', 'type': 'education', 'lineage': ['https://openalex.org/I124357947', 'https://openalex.org/I142947616']}, {'id': 'https://openalex.org/I1325846038', 'display_name': 'Royal Marsden NHS Foundation Trust', 'ror': 'https://ror.org/0008wzh48', 'country_code': 'GB', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1325846038']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'A. Stewart', 'raw_affiliation_strings': ['The Drug Development Unit, Divisions of Cancer Therapeutics & Clinical Studies, The Institute of Cancer Research & The Royal Marsden NHS Foundation Trust, London, UK'], 'affiliations': [{'raw_affiliation_string': 'The Drug Development Unit, Divisions of Cancer Therapeutics & Clinical Studies, The Institute of Cancer Research & The Royal Marsden NHS Foundation Trust, London, UK', 'institution_ids': ['https://openalex.org/I142947616', 'https://openalex.org/I1325846038']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5072378199', 'display_name': 'Johann S. de Bono', 'orcid': 'https://orcid.org/0000-0002-2034-595X'}, 'institutions': [{'id': 'https://openalex.org/I142947616', 'display_name': 'Institute of Cancer Research', 'ror': 'https://ror.org/043jzw605', 'country_code': 'GB', 'type': 'education', 'lineage': ['https://openalex.org/I124357947', 'https://openalex.org/I142947616']}, {'id': 'https://openalex.org/I1325846038', 'display_name': 'Royal Marsden NHS Foundation Trust', 'ror': 'https://ror.org/0008wzh48', 'country_code': 'GB', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1325846038']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'J.S. de Bono', 'raw_affiliation_strings': ['The Drug Development Unit, Divisions of Cancer Therapeutics & Clinical Studies, The Institute of Cancer Research & The Royal Marsden NHS Foundation Trust, London, UK'], 'affiliations': [{'raw_affiliation_string': 'The Drug Development Unit, Divisions of Cancer Therapeutics & Clinical Studies, The Institute of Cancer Research & The Royal Marsden NHS Foundation Trust, London, UK', 'institution_ids': ['https://openalex.org/I142947616', 'https://openalex.org/I1325846038']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5001503641', 'display_name': 'Mary O’Brien', 'orcid': 'https://orcid.org/0000-0002-8557-8957'}, 'institutions': [{'id': 'https://openalex.org/I1325846038', 'display_name': 'Royal Marsden NHS Foundation Trust', 'ror': 'https://ror.org/0008wzh48', 'country_code': 'GB', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1325846038']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'M.E.R. O’Brien', 'raw_affiliation_strings': ['The Lung Unit, The Royal Marsden NHS Foundation Trust, London, UK'], 'affiliations': [{'raw_affiliation_string': 'The Lung Unit, The Royal Marsden NHS Foundation Trust, London, UK', 'institution_ids': ['https://openalex.org/I1325846038']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5048231332', 'display_name': 'Sanjay Popat', 'orcid': 'https://orcid.org/0000-0003-2087-4963'}, 'institutions': [{'id': 'https://openalex.org/I1325846038', 'display_name': 'Royal Marsden NHS Foundation Trust', 'ror': 'https://ror.org/0008wzh48', 'country_code': 'GB', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1325846038']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'S. Popat', 'raw_affiliation_strings': ['The Lung Unit, The Royal Marsden NHS Foundation Trust, London, UK'], 'affiliations': [{'raw_affiliation_string': 'The Lung Unit, The Royal Marsden NHS Foundation Trust, London, UK', 'institution_ids': ['https://openalex.org/I1325846038']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5022215471', 'display_name': 'Jaishree Bhosle', 'orcid': 'https://orcid.org/0000-0002-9942-9696'}, 'institutions': [{'id': 'https://openalex.org/I1325846038', 'display_name': 'Royal Marsden NHS Foundation Trust', 'ror': 'https://ror.org/0008wzh48', 'country_code': 'GB', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1325846038']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'J. Bhosle', 'raw_affiliation_strings': ['The Lung Unit, The Royal Marsden NHS Foundation Trust, London, UK'], 'affiliations': [{'raw_affiliation_string': 'The Lung Unit, The Royal Marsden NHS Foundation Trust, London, UK', 'institution_ids': ['https://openalex.org/I1325846038']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5032401979', 'display_name': 'Udai Banerji', 'orcid': 'https://orcid.org/0000-0003-1503-3123'}, 'institutions': [{'id': 'https://openalex.org/I142947616', 'display_name': 'Institute of Cancer Research', 'ror': 'https://ror.org/043jzw605', 'country_code': 'GB', 'type': 'education', 'lineage': ['https://openalex.org/I124357947', 'https://openalex.org/I142947616']}, {'id': 'https://openalex.org/I1325846038', 'display_name': 'Royal Marsden NHS Foundation Trust', 'ror': 'https://ror.org/0008wzh48', 'country_code': 'GB', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1325846038']}], 'countries': ['GB'], 'is_corresponding': True, 'raw_author_name': 'U. Banerji', 'raw_affiliation_strings': ['The Drug Development Unit, Divisions of Cancer Therapeutics & Clinical Studies, The Institute of Cancer Research & The Royal Marsden NHS Foundation Trust, London, UK'], 'affiliations': [{'raw_affiliation_string': 'The Drug Development Unit, Divisions of Cancer Therapeutics & Clinical Studies, The Institute of Cancer Research & The Royal Marsden NHS Foundation Trust, London, UK', 'institution_ids': ['https://openalex.org/I142947616', 'https://openalex.org/I1325846038']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 2, 'corresponding_author_ids': ['https://openalex.org/A5032401979'], 'corresponding_institution_ids': ['https://openalex.org/I142947616', 'https://openalex.org/I1325846038'], 'apc_list': {'value': 3110, 'currency': 'USD', 'value_usd': 3110, 'provenance': 'doaj'}, 'apc_paid': None, 'fwci': 1.235, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 21, 'citation_normalized_percentile': {'value': 0.804887, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 91, 'max': 92}, 'biblio': {'volume': '85', 'issue': '2', 'first_page': '141', 'last_page': '146'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10952', 'display_name': 'mTOR Signaling in Growth and Disease', 'score': 0.9996, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10952', 'display_name': 'mTOR Signaling in Growth and Disease', 'score': 0.9996, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T10417', 'display_name': 'Advancements in Lung Cancer Research', 'score': 0.9995, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T12318', 'display_name': 'Chemistry and Pharmacology of Quinazoline Compounds', 'score': 0.9983, 'subfield': {'id': 'https://openalex.org/subfields/1605', 'display_name': 'Organic Chemistry'}, 'field': {'id': 'https://openalex.org/fields/16', 'display_name': 'Chemistry'}, 'domain': {'id': 'https://openalex.org/domains/3', 'display_name': 'Physical Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/egfr-mutations', 'display_name': 'EGFR Mutations', 'score': 0.525916}, {'id': 'https://openalex.org/keywords/alk-inhibitors', 'display_name': 'ALK Inhibitors', 'score': 0.50923}, {'id': 'https://openalex.org/keywords/egfr-inhibitors', 'display_name': 'EGFR inhibitors', 'score': 0.47734907}, {'id': 'https://openalex.org/keywords/growth-inhibition', 'display_name': 'Growth inhibition', 'score': 0.4390257}], 'concepts': [{'id': 'https://openalex.org/C2780580887', 'wikidata': 'https://www.wikidata.org/wiki/Q417824', 'display_name': 'Gefitinib', 'level': 4, 'score': 0.8767577}, {'id': 'https://openalex.org/C75217442', 'wikidata': 'https://www.wikidata.org/wiki/Q423650', 'display_name': 'Protein kinase B', 'level': 3, 'score': 0.7869719}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.62896305}, {'id': 'https://openalex.org/C190283241', 'wikidata': 'https://www.wikidata.org/wiki/Q14599311', 'display_name': 'Apoptosis', 'level': 2, 'score': 0.59113604}, {'id': 'https://openalex.org/C62112901', 'wikidata': 'https://www.wikidata.org/wiki/Q189159', 'display_name': 'Cell growth', 'level': 2, 'score': 0.5643524}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.5273398}, {'id': 'https://openalex.org/C2779438470', 'wikidata': 'https://www.wikidata.org/wiki/Q424401', 'display_name': 'Epidermal growth factor receptor', 'level': 3, 'score': 0.48559707}, {'id': 'https://openalex.org/C2778087573', 'wikidata': 'https://www.wikidata.org/wiki/Q418369', 'display_name': 'Erlotinib', 'level': 4, 'score': 0.4806189}, {'id': 'https://openalex.org/C86554907', 'wikidata': 'https://www.wikidata.org/wiki/Q285613', 'display_name': 'PI3K/AKT/mTOR pathway', 'level': 3, 'score': 0.47740498}, {'id': 'https://openalex.org/C2777506169', 'wikidata': 'https://www.wikidata.org/wiki/Q424401', 'display_name': 'EGFR inhibitors', 'level': 4, 'score': 0.47734907}, {'id': 'https://openalex.org/C2776256026', 'wikidata': 'https://www.wikidata.org/wiki/Q47912', 'display_name': 'Lung cancer', 'level': 2, 'score': 0.46952668}, {'id': 'https://openalex.org/C2779707156', 'wikidata': 'https://www.wikidata.org/wiki/Q5611758', 'display_name': 'Growth inhibition', 'level': 3, 'score': 0.4390257}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.3397688}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.3346128}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.2795096}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.2578941}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.2506218}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.11776453}], 'mesh': [{'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D017209', 'descriptor_name': 'Apoptosis', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': True}, {'descriptor_ui': 'D002289', 'descriptor_name': 'Carcinoma, Non-Small-Cell Lung', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': True}, {'descriptor_ui': 'D008175', 'descriptor_name': 'Lung Neoplasms', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': True}, {'descriptor_ui': 'D047428', 'descriptor_name': 'Protein Kinase Inhibitors', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D051057', 'descriptor_name': 'Proto-Oncogene Proteins c-akt', 'qualifier_ui': 'Q000037', 'qualifier_name': 'antagonists & inhibitors', 'is_major_topic': True}, {'descriptor_ui': 'D011799', 'descriptor_name': 'Quinazolines', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D017209', 'descriptor_name': 'Apoptosis', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D002289', 'descriptor_name': 'Carcinoma, Non-Small-Cell Lung', 'qualifier_ui': 'Q000235', 'qualifier_name': 'genetics', 'is_major_topic': False}, {'descriptor_ui': 'D002289', 'descriptor_name': 'Carcinoma, Non-Small-Cell Lung', 'qualifier_ui': 'Q000473', 'qualifier_name': 'pathology', 'is_major_topic': False}, {'descriptor_ui': 'D002289', 'descriptor_name': 'Carcinoma, Non-Small-Cell Lung', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D045744', 'descriptor_name': 'Cell Line, Tumor', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004357', 'descriptor_name': 'Drug Synergism', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D066246', 'descriptor_name': 'ErbB Receptors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D066246', 'descriptor_name': 'ErbB Receptors', 'qualifier_ui': 'Q000037', 'qualifier_name': 'antagonists & inhibitors', 'is_major_topic': False}, {'descriptor_ui': 'D066246', 'descriptor_name': 'ErbB Receptors', 'qualifier_ui': 'Q000235', 'qualifier_name': 'genetics', 'is_major_topic': False}, {'descriptor_ui': 'D000077156', 'descriptor_name': 'Gefitinib', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D020128', 'descriptor_name': 'Inhibitory Concentration 50', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008175', 'descriptor_name': 'Lung Neoplasms', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008175', 'descriptor_name': 'Lung Neoplasms', 'qualifier_ui': 'Q000235', 'qualifier_name': 'genetics', 'is_major_topic': False}, {'descriptor_ui': 'D008175', 'descriptor_name': 'Lung Neoplasms', 'qualifier_ui': 'Q000473', 'qualifier_name': 'pathology', 'is_major_topic': False}, {'descriptor_ui': 'D009154', 'descriptor_name': 'Mutation', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009154', 'descriptor_name': 'Mutation', 'qualifier_ui': 'Q000235', 'qualifier_name': 'genetics', 'is_major_topic': False}, {'descriptor_ui': 'D047428', 'descriptor_name': 'Protein Kinase Inhibitors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D051057', 'descriptor_name': 'Proto-Oncogene Proteins c-akt', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011799', 'descriptor_name': 'Quinazolines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015398', 'descriptor_name': 'Signal Transduction', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D015398', 'descriptor_name': 'Signal Transduction', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1016/j.lungcan.2014.05.008', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S100767427', 'display_name': 'Lung Cancer', 'issn_l': '0169-5002', 'issn': ['0169-5002', '1872-8332'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320990', 'host_organization_name': 'Elsevier BV', 'host_organization_lineage': ['https://openalex.org/P4310320990'], 'host_organization_lineage_names': ['Elsevier BV'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/24957682', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'score': 0.79, 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 24, 'referenced_works': ['https://openalex.org/W1576497688', 'https://openalex.org/W1972512448', 'https://openalex.org/W1990244940', 'https://openalex.org/W1996092483', 'https://openalex.org/W1998550865', 'https://openalex.org/W1998682097', 'https://openalex.org/W2014096417', 'https://openalex.org/W2014517538', 'https://openalex.org/W2026707626', 'https://openalex.org/W2052111639', 'https://openalex.org/W2059394181', 'https://openalex.org/W2071396933', 'https://openalex.org/W2093375307', 'https://openalex.org/W2096439168', 'https://openalex.org/W2115484306', 'https://openalex.org/W2117497402', 'https://openalex.org/W2128696591', 'https://openalex.org/W2129360604', 'https://openalex.org/W2135192471', 'https://openalex.org/W2150079073', 'https://openalex.org/W2153447740', 'https://openalex.org/W2159750196', 'https://openalex.org/W2164194457', 'https://openalex.org/W2327437619'], 'related_works': ['https://openalex.org/W3147989365', 'https://openalex.org/W2418692205', 'https://openalex.org/W2408927976', 'https://openalex.org/W2348666640', 'https://openalex.org/W2280113021', 'https://openalex.org/W2254126652', 'https://openalex.org/W2168841302', 'https://openalex.org/W2120992361', 'https://openalex.org/W2103997800', 'https://openalex.org/W2015104488'], 'abstract_inverted_index': {'EGFR': [0, 6, 25, 71, 75, 191], 'inhibitors': [1], 'are': [2, 17], 'ineffective': [3], 'against': [4], 'most': [5], 'wild-type': [7, 76], 'non-small': [8, 60, 77, 206], 'cell': [9, 61, 64, 78, 81, 120, 147, 207], 'lung': [10, 62, 79, 208], 'cancer,': [11], 'for': [12, 23, 124, 200], 'which': [13], 'novel': [14], 'treatment': [15], 'strategies': [16], 'needed.': [18], 'AKT': [19, 39, 178, 193], 'signalling': [20, 175], 'is': [21], 'essential': [22], 'mediating': [24], 'survival': [26], 'signals': [27], 'in': [28, 51, 69, 118, 141, 160], 'NSCLC.': [29], 'We': [30], 'evaluated': [31], 'the': [32, 41, 46, 125], 'combination': [33, 85, 107, 126], 'of': [34, 108, 127, 152, 174, 190], 'gefitinib': [35, 109, 128, 167], 'and': [36, 45, 54, 56, 73, 99, 110, 129, 138, 145, 155, 162, 179, 184, 192, 204], 'two': [37, 70, 74], 'different': [38], 'inhibitors,': [40], 'allosteric': [42], 'inhibitor': [43, 49], 'AKTi-1/2': [44, 111, 130], 'ATP-competitive': [47], 'pan-AKT': [48], 'AZD5363,': [50], 'EGFR-mutant': [52, 203], '(HCC-827': [53], 'PC-9)': [55], '-wild-type': [57, 205], '(NCI-H522,': [58], 'NCI-H1651),': [59], 'cancer': [63, 80], 'lines.Drug': [65], 'interaction': [66], 'was': [67, 168], 'studied': [68, 102], 'mutant': [72], 'lines': [82], 'by': [83, 103], 'calculating': [84], 'index': [86], '(CI)': [87], 'using': [88], 'median': [89], 'effect': [90], 'analysis.': [91], 'The': [92], 'effects': [93], 'on': [94], 'p-EGFR,': [95], 'p-ERK,': [96], 'p-AKT,': [97], 'p-S6': [98], 'apoptosis': [100, 186], 'were': [101, 131, 158, 187], 'Western': [104], 'blot': [105], 'analysis.The': [106], 'or': [112], 'AZD5363': [113], 'showed': [114], 'synergistic': [115], 'growth': [116], 'inhibition': [117, 173, 189], 'all': [119], 'lines.': [121], 'CI': [122, 150], 'values': [123, 151], '0.35': [132], '(p=0.0048),': [133], '0.56': [134], '(p=0.036),': [135], '0.75': [136], '(p=0.13)': [137], '0.64': [139], '(p=0.0003)': [140], 'NCI-H522,': [142], 'NCI-H1651,': [143], 'HCC-827': [144], 'PC-9': [146, 163], 'lines,': [148], 'respectively;': [149], '0.45': [153], '(p=0.0087)': [154], '0.22': [156], '(p<0.0001)': [157], 'observed': [159], 'NCI-H522': [161], 'cells,': [164], 'respectively,': [165], 'when': [166], 'combined': [169], 'with': [170, 202], 'AZD5363.': [171], 'Additive': [172], 'output': [176], 'through': [177], 'key': [180], 'downstream': [181], 'proteins': [182], '(S6)': [183], 'increased': [185], 'demonstrated.Dual': [188], 'may': [194], 'be': [195], 'a': [196], 'useful': [197], 'up-front': [198], 'strategy': [199], 'patients': [201], 'cancer.': [209]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W1974847342', 'counts_by_year': [{'year': 2023, 'cited_by_count': 2}, {'year': 2022, 'cited_by_count': 3}, {'year': 2021, 'cited_by_count': 1}, {'year': 2020, 'cited_by_count': 2}, {'year': 2019, 'cited_by_count': 1}, {'year': 2018, 'cited_by_count': 2}, {'year': 2017, 'cited_by_count': 2}, {'year': 2016, 'cited_by_count': 4}, {'year': 2015, 'cited_by_count': 4}], 'updated_date': '2024-09-17T14:55:53.454763', 'created_date': '2016-06-24'}